CEO Wa'el Hashad steps down; Than Powell interim CEO; Joshua Hare Executive Chairman

Longeveron Inc.

Wa'el Hashad resigned as CEO and board member effective August 27, 2025 to pursue other opportunities.
Than Powell, former Chief Business Officer, appointed interim CEO effective September 4, 2025; base salary $500,000 with target bonus.
Founder and CSO Dr. Joshua Hare appointed Executive Chairman; board plans national search for permanent CEO.
Powell has 25+ years pharma/biotech leadership at GSK, Eli Lilly, Surescripts, and Epulate.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.